Fermentation-Based Pharmaceutical Wastewater Treatment: 300–1000 m³/day Full-Scale Solution

Why Fermentation-Based Pharmaceutical Wastewater is Challenging

Fermentation-based pharmaceutical wastewater comes from microbial fermentation processes used in producing antibiotics, amino acids, and vitamins. Its main challenges:

• High organic load: COD often 5,000–50,000 mg/L, sometimes exceeding 100,000 mg/L.
• Biological inhibition: Residual antibiotics and solvents can harm microbes.
• High sulfate content: 1,000–5,000 mg/L SO₄²⁻ produces H₂S, inhibiting methanogens.
• High ammonia nitrogen: NH₄⁺ 200–2,000 mg/L.
• Severe water quality fluctuations: Batch fermentation creates variable influent.

Treatment Scale: 300–1000 m³/day

Typical influent:

• COD: 8,000–30,000 mg/L
• BOD₅: 3,000–12,000 mg/L
• SS: 500–2,000 mg/L
• Ammonia nitrogen: 300–800 mg/L
• Sulfate: 800–3,000 mg/L
• pH: 4–10

Effluent target (GB 21903–2008 or stricter):

• COD ≤ 120 mg/L
• BOD₅ ≤ 30 mg/L
• NH₄⁺ ≤ 35 mg/L
• TP ≤ 1 mg/L
• Color ≤ 80

Recommended process: Pre-treatment → Anaerobic (IC/EGSB) → Aerobic MBR → Advanced Treatment

Stage 1: Pre-Treatment — Detoxification & Homogenization

Goals: Reduce toxicity, stabilize influent, remove solids.

• Segregation & Buffering: 1.5–2× daily volume; online COD/pH monitoring.
• Physical-Chemical Treatment: pH adjustment to 6.5–7.5; SS removal via DAF or sedimentation.
• High-Strength Liquor Treatment: Micro-electrolysis or Fenton oxidation improves biodegradability; MVR evaporation for concentrated streams.
• Sulfate Management: Dilution, CaSO₄ precipitation, Fe dosing to prevent H₂S.

Stage 2: Anaerobic Treatment — Core COD Removal

Objective: Convert high-strength organics to methane, reduce COD for MBR.

• Reactor Choice:
• IC Reactor: HRT 4–6 h, volumetric load 15–25 kg COD/m³·d.
• EGSB: HRT longer, better sulfate tolerance, volumetric load 8–15 kg COD/m³·d.
• Key Parameters: COD/SO₄²⁻ ≥ 8, SO₄²⁻ < 1,500 mg/L, H₂S < 200 mg/L, 35–38°C, alkalinity 2,000–3,000 mg/L CaCO₃.
• Biogas: 300–2,000 m³/day, used for heating, saving energy.

Stage 3: MBR Aerobic Treatment — Polishing Effluent

Advantages:

• MLSS 8,000–15,000 mg/L
• COD < 50 mg/L, NH₄⁺ < 5 mg/L, SS ≈ 0
• Small footprint, long sludge retention (30–60 days)

Design:

• HRT: 12–24 h
• DO: 2–4 mg/L (0.5 mg/L in anoxic zones)
• Membrane flux: 8–12 L/m²·h

Fouling Control:

• Maintain SS < 200 mg/L
• Air scour 10:1–15:1
• Chemical cleaning: NaClO for routine/maintenance

Stage 4: Advanced Treatment — Final Polishing

• Ozone oxidation: 10–30 mg/L, breaks down antibiotics, reduces color/odor
• Activated carbon (GAC): EBCT ≥ 10 min for residual organics
• UV disinfection: Dose ≥ 30 mJ/cm²

Equipment & Technical Highlights

• Buffer tanks: 1.5–2× daily volume, online monitoring
• Fenton reactor: HRT 30–60 min, H₂O₂/Fe²⁺ 5:1–10:1
• IC reactor: High aspect ratio, temperature control, H₂S monitoring
• MBR: PVDF hollow-fiber, 0.04–0.1 μm, flux 8–12 L/m²·h, auto-cleaning
• Ozone tower: Packed-bed or plate, tail-gas destruction

Case Studies

• East China Antibiotic Plant (500 m³/day): Fenton + sulfate precipitation + IC + A/O-MBR + ozone → COD 80–100 mg/L, NH₄⁺ < 10 mg/L, biogas used for heating.
• Southwest Vitamin C Plant (800 m³/day): MVR + dilution + EGSB + MBR + GAC → Stable operation, COD/SO₄²⁻ ≥ 9.

FAQs

• Why acidification in anaerobic? VFA buildup due to low COD/SO₄²⁻, temperature drop, or low pH. Solution: stop influent, add bicarbonate, adjust temperature.
• Why MBR flux drop? Increase aeration, physical/chemical cleaning, replace membrane if needed.
• Why control COD/SO₄²⁻ ratio? High ratio favors methanogens; low ratio (❤) causes H₂S accumulation.

Conclusion

For 300–1000 m³/day fermentation pharmaceutical wastewater, success relies on:

• Solid pre-treatment & buffer tanks
• Sulfate management
• Precise anaerobic operation
• MBR maintenance

Investments are justified by long-term operational stability, energy savings, and regulatory compliance.